Physician profile
John Frank Mcleod
NPI 1154480028
$3,656.43
in general payments reported to CMS, 2019-2025
26 companies · $215 in 2025
The $215 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,693 · 2020: $505 · 2021: $672 · 2022: $252 · 2023: $96.50 · 2024: $223 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $503 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $502.95 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,356.67 | 2019 | |
| Merck Sharp & Dohme LLC | $324.85 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $289.90 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $273.35 | 2019-2024 | Jardiance |
| Janssen Pharmaceuticals, INC | $218.87 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $202.99 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $185.68 | 2019-2025 | Ozempic, Rybelsus |
| Xeris Pharmaceuticals, INC. | $178.80 | 2021-2024 | Gvoke Hypopen |
| Amarin Pharma, INC. | $78.77 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $69.25 | 2021-2022 | |
| Amgen INC. | $60.59 | 2019-2021 | |
| Abbvie INC. | $57.18 | 2021-2022 | |
| Dexcom, INC. | $46.66 | 2025 | Dexcom G6 Transmitter |
| Horizon Therapeutics Plc | $40.54 | 2020-2021 | |
| Allergan, INC. | $39.73 | 2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $36.35 | 2020-2021 | |
| Exact Sciences Corporation | $35.02 | 2025 | Cologuard Collection Kit |
| Esperion Therapeutics, INC. | $25.23 | 2020-2021 | |
| Eisai INC. | $21.74 | 2021 | |
| Phathom Pharmaceuticals, INC. | $18.73 | 2024 | Voquezna |
| Seqirus USA INC | $18.11 | 2025 | Fluad, Flucelvax |
| Vifor Pharma, INC. | $17.42 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.88 | 2022 | |
| Mylan Specialty L.P. | $14.40 | 2019 | |
| Pfizer INC. | $14.38 | 2021 | |
| Abbott Laboratories | $14.34 | 2024 | Freestyle Libre 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mcleod listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.